Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05228132 · ClinicalTrials.gov registry record · NA
The Pristine Post-Market Study
A NA study, sponsored by C. R. Bard.
- Terminated
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT05228132 is a NA study that was terminated before completion, run by C. R. Bard. The registered enrollment target is 142 participants.
The verdict
NCT05228132, a NA study, was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, single-arm study designed to assess the safety and performance of the Pristine™ Long-Term Hemodialysis Catheter.
Interventions
- DEVICE Pristine™ Long-Term Hemodialysis Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2022-05-16 |
| Est. Completion | 2022-09-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05228132
The ClinicalTrials.gov registry entry for NCT05228132 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pristine™ Long-Term Hemodialysis Catheter is the first listed.
NCT05228132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05228132 about?
NCT05228132 is a clinical study titled "The Pristine Post-Market Study". This is a prospective, multi-center, single-arm study designed to assess the safety and performance of the Pristine™ Long-Term Hemodialysis Catheter.
What is the current status of trial NCT05228132?
This trial is currently terminated. It is a NA study. The enrollment target is 142 participants. The study started on 2022-05-16. Estimated completion is 2022-09-21.
What interventions are being tested in trial NCT05228132?
The interventions under investigation include: Pristine™ Long-Term Hemodialysis Catheter (DEVICE).
Who is sponsoring clinical trial NCT05228132?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.